| Dr Lindsay Beth Jones, MD | |
|
4660 Kenmore Ave Ste 220, Alexandria, VA 22304-1306 | |
| (703) 888-2034 | |
| Not Available |
| Full Name | Dr Lindsay Beth Jones |
|---|---|
| Gender | Female |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 11 Years |
| Location | 4660 Kenmore Ave Ste 220, Alexandria, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609213198 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Affiliates In Plastic Surgery, Llc | 2365664117 | 8 |
News Archive
Vanderbilt faculty and researchers are looking for the "Achilles' heel" of the cancer cells that survive initial chemotherapy.
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
› Verified 9 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
Vanderbilt faculty and researchers are looking for the "Achilles' heel" of the cancer cells that survive initial chemotherapy.
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
› Verified 9 days ago
| Entity Name | Affiliates In Plastic Surgery, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164848529 PECOS PAC ID: 2365664117 Enrollment ID: O20141111000271 |
News Archive
Vanderbilt faculty and researchers are looking for the "Achilles' heel" of the cancer cells that survive initial chemotherapy.
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lindsay Beth Jones, MD 4660 Kenmore Ave Ste 220, Alexandria, VA 22304-1306 Ph: (703) 888-2034 | Dr Lindsay Beth Jones, MD 4660 Kenmore Ave Ste 220, Alexandria, VA 22304-1306 Ph: (703) 888-2034 |
News Archive
Vanderbilt faculty and researchers are looking for the "Achilles' heel" of the cancer cells that survive initial chemotherapy.
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) to treat prostate cancer offers a higher cure rate than more traditional approaches, according to researchers at UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center.
Older patients with hormone receptor-positive breast cancer who did not receive radiation therapy after breast-conserving surgery had higher rates of local recurrence but similar 10-year survival rates when compared to patients who received postoperative radiation therapy, according to updated 10-year data from the PRIME II study, presented at the 2020 San Antonio Breast Cancer Symposium, held Dec. 8-11.
› Verified 9 days ago
Stefano Franco Agolini, Surgery Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave, Suite 419, Alexandria, VA 22304 Phone: 703-823-4066 Fax: 703-823-4067 | |
Dr. David C Weintritt, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 277 S Washington St Ste 100, Alexandria, VA 22314 Phone: 571-366-5792 Fax: 571-366-5793 | |
Dr. Susan K Buenaventura, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: 5425 Duke Street, Alexandria, VA 22304 Phone: 703-751-0800 Fax: 703-751-4378 | |
Dr. Clarisa C. Hammer, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave Ste 220, Alexandria, VA 22304 Phone: 703-832-4000 Fax: 703-832-4001 | |
Dr. Albert D Sam Ii, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1800 N Beauregard St Ste 50, Alexandria, VA 22311 Phone: 703-205-7330 Fax: 703-205-7331 | |
Michael Francis Nigro Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 4660 Kenmore Ave, Ste 220, Alexandria, VA 22304 Phone: 703-823-5900 Fax: 703-751-1849 |